Black Rock Inc. Alkermes Plc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,107,548 shares of ALKS stock, worth $811 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,107,548
Previous 29,168,481
0.21%
Holding current value
$811 Million
Previous $790 Million
11.16%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Vanguard Group Inc Valley Forge, PA18.5MShares$516 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$280 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$229 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$179 Million1.86% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.81MShares$162 Million0.24% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.58B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...